Patent · US Active

Inhibitors of protein kinases

US10533001B2 · kind B2 · utility

5Cited by

104References

13Claims

0Family size

Assignee

Portola Pharmaceuticals, Inc. · US

Inventors

Shawn M. Bauer · Pacifica, US
Zhaozhong J. Jia · San Mateo, US
Mukund Mehrotra · South San Francisco, US
Yonghong Song · Foster City, US
Qing Xu · South San Francisco, US
Wolin Huang · Foster City, US
Chandrasekar Venkataramani · Redwood City, US
Jack W. Rose · San Mateo, US
Anjali Pandey · Fremont, US

Key dates

Filing date	Nov 30, 2017
Grant date	Jan 14, 2020
Priority date	—
Expiry date	Nov 30, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to topical pharmaceutical compositions of Formula (If) or pharmaceutically acceptable salt thereof, which act as inhibitors of syk and/or JAK kinase activity. The described topical pharmaceutical compositions are useful in preventing or treating a number of conditions mediated at least in part by syk and/or JAK kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.